Inter-connected Enterprises Limited.
Like us on Facebook   Tweet us on Twitter   Follow us on Linked In  
Home | Downloads | Feedback | Careers | Contact Us
  News Analysis
  Pre-Session Commentary
  Mid-Session Commentary
  End-Session Commentary
  Hot Pursuit
  Foreign Markets
  Other Markets
  Corporate News
  Market Beat
  Economy News
  Political News
  Corporate Results
  Stock Alert
  Market Analysis
  Gainers & Losers
  Advances & Declines
  Value Toppers
  New High & Lows
  52 Wk High Low
  Bulk Deals
  Block Deals
  Other Markets
  FII Investments
  MF Investments
  ADR Prices
  World Indices
  Corporate Actions
  Announcements
  Board Meetings
  Book Closure
  Bonus Issues
  Rights Issues
  Change Of Name
  Delisted Shares
  Market Turnover
  Split Of Face Value
  Corporate Info
  Get Quotes
  Company Background
  Board Of Directors
  Balance Sheet
  Quarterly Results
  Profit & Loss Account
  Key Financial Ratios
  Share Prices
  Technical Charts
  IPOs
  Upcoming Issues
  Open Issues
  Closed Issues
  New Listing
  Basis Of Allotment
  Draft Prospectus
  New Issue Monitor
  Mutual Fund
  Fund Profile Sheet
  Scheme Profile Sheet
  Daily NAV
  MF Synopsis
  Historical NAV
  Dividend Details
  MF Activities
  Top 10 Holdings
  MF News
  FAQs
  Derivatives
  Get Quotes
  Nifty Futures
  Top Quantity in FO
  Top Value Traded in FO
  Derivative Summary
  FII Statistics
  Daily Settlement Price
  List Of Underlying
  Put Call Ratio
  Most Active Put
  Most Active Call
  All Index Future
  Top Gainers
  Top Losers
  Highest in OI
  Lowest in OI
  Increase in OI
  Decline in OI
  Most Active Contracts
  NSE Currency Futures
  MCX Currency Futures
  Commodity
  Get Quotes
  Gainers & Losers
  Top Traded Value
  Advances & Declines
  Closing Prices
  Highs & Lows
  Technical Chart
 
 
You are here : Equity > IPO > Ongoing Issues > IPO Synopsis
Details of current issues such as Company name, Open / Close date, Offer Price along with Issue Size.
Senores Pharmaceuticals Ltd
Registered Office: #.1101-1103 11th Flr South Twr,Ambali Bopal Road , Ahmedabad - 380054 , Gujarat , India.
Phone : +91-79-2999 9857   Fax:
Email :  cs@senorespharma.com  
Website :  www.senorespharma.com
Initial public offering of up to [*] equity shares of face value of Rs. 10 each ("Equity Shares") of Senores Pharmaceuticals Limited ("The Company" or the "Issuer") for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) ("Offer Price") aggregating up to Rs. [*] crores (the "Offer"). The offer comprises of a fresh issue of upto [*] equity shares by the company aggregating upto Rs. 500.00 crores (the "Fresh Issue") and an offer for sale of up to 2,100,000 equity shares (the "Offered Shares") aggregating up to Rs. [*] crores (the "Offer for Sale"), comprising up to 250,000 equity shares aggregating to Rs. [*] crores by Swapnil Jatinbhai Shah, up to 550,000 equity shares aggregating to Rs. [*] crores by Ashokkumar Vijaysinh Barot, up to 300,000 equity shares aggregating to Rs. [*] crores by Sangeeta Mukur Barot and up to 1,000,000 equity shares aggregating to Rs. [*] crores by Prakash M Sanghvi (the "Selling Shareholders"). The offer shall constitute [*] % of the post-offer paid-up equity share capital of the company. The offer includes a reservation of up to 75,000 equity shares, aggregating up to Rs. [*] crores (constituting [*] of the post-offer paid-up equity share capital, for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". Price Band: Rs. 372 to Rs. 391 per equity share of face value of Rs. 10 each. The Floor price is 37.20 times the face value of the equity shares and cap price is 39.10 times the face value of the equity shares. Bid can be made for a minimum of 38 equity shares and in multiples of 38 equity shares.

Issue Money Payable On
Opens On Closes On Application Allotment
20-Dec-24 24-Dec-24 372.00-391.00 0.00-0.00
Minimum Application for shares in Nos :38  Further Multiples of :38

  Cr Lead Managers to the Issue
Project Cost 0.00
Ambit Pvt Ltd
Project Financed through Current Offer 578.12  
Post Issue Equity Share Capital 46.05  
Issue Price 372.00  
 
Projects
Funding the capital expenditure requirements by investment in of one of your its subsidiary Havix,for setting up a mfg facility for the production of sterlie injection in its Atlanta FacilityFunding inorganic growth through acquisition and other strategic initiatives and general corporate purposes
Re-payment/pre-payment in full or in part of certain borrowings availed by the company and its subsidiary namely Havix Ratnatris and PSIInvestment in its subsidiary namely Havix for re-payment/pre-payment in full or in part of certain borrowings availd by the subsidiaries
Funding the working capital requirements of the company and its subsidiary namely SPI ad RatnatrisInvestment in its subsidiary namely SPI and Ratnatri to fund their working capital requirements
Promoted By
 Swapnil Jatinbhai
 Ashokkumar Vijaysingh Barot
 Anar Swapnil Shah
Listing At
 BSE 
 NSE 
Registrar to the Issue
 Link Intime India Pvt Ltd